Mantle cell lymphoma New Reference: Acalabrutinib with R-Bendamustine in Untreated Mantle Cell Lymphoma Ulas D. Bayraktar, MD 2025-05-04
Mantle cell lymphoma New Indication: Ibrutinib with Venetoclax for Mantle Cell Lymphoma Ulas D. Bayraktar, MD 2025-03-02
Mantle cell lymphoma New Protocol: Acalabrutinib with R-Bendamustine for Mantle Cell Lymphoma Ulas D. Bayraktar, MD 2025-01-19
Mantle cell lymphoma New Drug: Pirtobrutinib in Mantle Cell Lymphoma Ulas D. Bayraktar, MD 2023-03-15
Mantle cell lymphoma New Protocol: Ibrutinib with Rituximab and Bendamustine for Mantle Cell Lymphoma Ulas D. Bayraktar, MD 2022-09-20
